Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085]

IF 4.8 2区医学 Q1 Biochemistry, Genetics and Molecular Biology

Neoplasia Pub Date : 2025-05-29 DOI:10.1016/j.neo.2025.101183

Kanchana Subramani , Hsuan-Shun Huang , Pao-Chu Chen , Dah-Ching Ding , Tang-Yuan Chu

引用次数: 0

查看原文本刊更多论文

“排卵源ROS赋予输卵管上皮TP53基因诱变活性”的更正[Neoplasia 59 (2025 Dec 4) 101085]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neoplasia 医学-肿瘤学

CiteScore

9.20

自引率

2.10%

发文量

审稿时长

26 days

期刊介绍： Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.